Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2015; 5(9): 016-020


Evaluation of antimicrobial activities of Bacillus megaterium with a third-generation cephalosporin (ceftriaxone)

Tu HK Nguyen, Le B Thu.




Abstract

Bacillus megaterium T04 isolated from Rach Lang stream in Vietnam was tested for antimicrobial activities. The antimicrobial activities of Bacillus megaterium T04 (57.3x108 cfu/mL) against Candida albicans, Salmonella typhi, Pseudomonas aeruginosa, Staphylococcus sciuri, Micrococcus luteus were detected by agar well diffusion method in different cultivation conditions at three temperatures (25, 37, and 45oC) in three incubation periods (24, 48, and 72 hours). The efficacy of antimicrobial activities of this strain were determined in comparison with ceftriaxone activity against Candida albicans, Salmonella typhi, Pseudomonas aeruginosa, Staphylococcus scuiri, Micrococcus luteus. The antimicrobial activity potency was equivalent to ceftriaxone in a range ( 3.3 0.6 μg/mL to 46.5 6.2 μg/mL) for Candida albicans (0.9 0.2 μg/mL to 35.5 7.7 μg/mL) for Salmonella typhi, , (0.4 0.1 μg/mL to 28.4 4.4 μg/mL) for Pseudomonas aeruginosa, (119.8 21.2 μg/mL to 283.7 26.0 μg/mL) for Staphylococcus scuiri, (3.3 0.4 μg/mL to 64.4 7.4 μg/mL) for Micrococcus luteus.

Key words: antimicrobial activities, Bacillus megaterium T04, ceftriaxone, potency






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.